SUBLOCADE Long-term Outcomes
NCT05860959 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 480
Last updated 2025-10-16
Summary
This study will provide the opportunity to generate data on the long-term use of SUBLOCADE under real-world conditions, and to observe enduring changes in lifestyle, health, and sociodemographic factors that are part of the recovery process. Long-term patterns of abstinence/opioid misuse as well as measures of participants' physical, psychological, social, and economic well-being will be monitored to better understand factors associated with recovery from opioid use disorder (OUD). Therefore, this study will observe participants up to a maximum of 4 years.
Conditions
Sponsors & Collaborators
-
Indivior Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-31
- Primary Completion
- 2025-08-31
- Completion
- 2025-08-31
Countries
- United States
- Australia
- Canada
- Sweden
Study Locations
More Related Trials
-
SUBLOCADE Rapid Initiation Study
NCT03993392 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)
NCT00723749 ·Status: COMPLETED
-
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
NCT02357901 ·Status: COMPLETED ·Phase: PHASE3
-
Study of a Novel Subcutaneous Depot Formulation of Buprenorphine
NCT03715634 ·Status: COMPLETED ·Phase: PHASE1
-
Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan
NCT00901875 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED)
NCT00723697 ·Status: COMPLETED
-
Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)
NCT00684073 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder
NCT02510014 ·Status: COMPLETED ·Phase: PHASE3
-
Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects
NCT01738503 ·Status: COMPLETED ·Phase: PHASE2
-
Abuse Liability of Suboxone Versus Subutex
NCT00710385 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder
NCT03861338 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder
NCT02559973 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male Participants
NCT05974046 ·Status: COMPLETED ·Phase: PHASE1
-
Injectable Buprenorphine in Prison: A Preference Trial
NCT06880718 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants
NCT02180659 ·Status: COMPLETED ·Phase: PHASE3
-
Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films
NCT03744663 ·Status: WITHDRAWN ·Phase: PHASE2
-
Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects
NCT01846455 ·Status: COMPLETED ·Phase: PHASE4
-
Transfer of Subjects From Subutex/Suboxone to RBP-6300
NCT01582347 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use Disorder
NCT04976855 ·Status: COMPLETED ·Phase: PHASE1
-
Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
NCT05145764 ·Status: RECRUITING ·Phase: PHASE2
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)
NCT00725608 ·Status: COMPLETED
-
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
NCT00000302 ·Status: COMPLETED ·Phase: PHASE3
-
XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept
NCT03604159 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase)
NCT04278586 ·Status: COMPLETED ·Phase: NA